15th INTERNATIONAL CONGRESS OF PARKINSON'S

More documents

Recommendations

Info

Daily Schedule Wednesday 50 Wednesday, June 8, 2011 TICKET 4213 Parallel Session The non-dementia associated cognitive and behavioral features of Parkinson’s disease 15:00 – 17:00 Location: South Building, Level 700, Room 717AB Chairs: Dag Aarsland Stavanger, Norway Roger Barker Cambridge, United Kingdom 15:00 Dopamine and cognition: What have we learned from experimental studies? Antonio Strafella Toronto, ON, Canada 15:40 Mild Cognitive Impairment in Parkinson’s disease: What does it mean? Dag Aarsland Stavanger, Norway 16:20 Cognitive and behavioral problems related to STN DBS in Parkinson’s disease Paul Krack Grenoble, France At the conclusion of this session, participants should be better able to: 1. Describe the role of dopamine in normal cognitive processes 2. Recognize the entity and significance of Mild Cognitive Impairment (MCI) of Parkinson’s disease 3. Identify the cognitive and behavioral problems related to surgery for Parkinson’s disease Recommended Audience: Basic Scientists; Clinical Academicians; Practitioners; Students/Residents/Trainees TICKET 4307 Teaching Course Neurodegeneration: The role of environmental factors 15:00 – 17:00 Location: South Building, Level 800, Room 801A Chairs: Caroline Tanner Sunnyvale, CA, USA Louis Tan Singapore 15:00 A frequent question: The role of smoking, caffeine and nutrition in Parkinson’s disease Louis Tan Singapore 15:40 Toxin induced parkinsonism: The manganese cases Pille Taba Tartu, Estonia 16:20 Herbicides and pesticides in Parkinson’s disease Caroline Tanner Sunnyvale, CA, USA TICKET continued 4307 Teaching Course At the conclusion of this session, participants should be better able to: 1. Understand the role of environmental factors in Parkinson’s disease 2. Recognize the clinical features of toxin–induced parkinsonism 3. Describe the possible effects of pesticides in Parkinson’s disease Recommended Audience: Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees TICKET 4308 Teaching Course New Unified Parkinson’s Disease Rating Scale: MDS-UPDRS 15:00 – 17:00 Location: South Building, Level 800, Room 801B Chairs: Anette Schrag London, United Kingdom Christopher Goetz Chicago, IL, USA 15:00 Similarities and differences between the MDS-UPDRS and the original UPDRS Anette Schrag London, United Kingdom 15:40 Key characteristics of the MDS-UPDRS with emphasis on difficult items Glenn Stebbins Chicago, IL, USA 16:20 Application of the MDS-UPDRS Pablo Martínez-Martín Madrid, Spain At the conclusion of this session, participants should be better able to: 1. Identify similarities and differences between the MDS- UPDRS and the original UPDRS 2. Evaluate key characteristics of the MDS-UPDRS with emphasis on difficult items 3. Develop the capability to apply the MDS-UPDRS Recommended Audience: Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees
Wednesday, June 8, 2011 TICKET 4403 Skills Workshop Measuring the right things right: Use of assessment tools and interpretation of results 17:30 – 19:00 Location: South Building, Level 800, Room 801A In this interactive session, keys for selection of the appropriate rating scale and parameters for interpretation of change will be discussed. Peter Hagell Lund, Sweden Barbara Tilley Houston, TX, USA At the conclusion of this session, participants should be better able to: 1. Identify the most appropriate measurement instrument in relation to a particular research question 2. Determine the relation between rating scale attributes (validity, reliability, responsiveness) and parameters of change (‘smallest detectable difference’ and ‘minimally clinically important change’) 3. Interpret the data analysis related to the outcomes of a study and the importance of the change Recommended Audience: Clinical Academicians; Practitioners; Non-Physician Health Professionals; Students/Residents/Trainees TICKET 4404 Skills Workshop Eye movements and ophthalmologic exams: A door for a precise diagnosis 17:30 – 19:00 Location: South Building, Level 700, Room 701AB In this interactive session, an approach to the use and application of eye examinations for diagnosis and management of movement disorders will be presented. R. John Leigh Cleveland, OH, USA David Zee Ellicott City, MD, USA At the conclusion of this session, participants should be better able to: 1. Identify the most appropriate tests of ocular mobility and ophthalmologic examination for specific movement disorders 2. Determine what information can be obtained from eye movements and ophthalmologic exams and how to apply the results in daily practice 3. Integrate the knowledge relative to eye movement disorders and ophthalmologic manifestations with underlying pathology Recommended Audience: Clinical Academicians; Practitioners; Students/Residents/Trainees 15 th INTERNATIONAL CONGRESS OF PARKINSON’S DISEASE AND MOVEMENT DISORDERS TICKET 4505 Video Session Phenotypic clues to the correct diagnosis of genetic movement disorders 17:30 – 19:00 Location: South Building, Level 700, Room 716AB In this interactive session, the audience should be able to recognize the phenotypes of genetic movement disorders and interpret the clinical, biological or neuroimaging clues in order to identify the main etiologies of these diseases. Christine Klein Lübeck, Germany Asha Kishore Trivandrum, India At the conclusion of this session, participants should be better able to: 1. Discuss the diagnostic process for hereditary movement disorders 2. Identify the particular clinical features associated with hereditary movement disorders 3. Distinguish the different types of abnormal eye movements associated with genetic movement disorders Recommended Audience: Clinical Academicians; Practitioners; Students/Residents/Trainees TICKET 4506 Video Session Parkinson’s disease: What animal models tell us 17:30 – 19:00 Location: South Building, Level 700, Room 714AB This interactive video session will focus on a variety of animal models used for different purposes in the study of Parkinson’s disease. The faculty will demonstrate video examples of the animal behaviors and open the discussion to participants for their views on the strengths and weaknesses of these numerous models. Participants with new animal models may contact the faculty to include their models for presentation and group discussion. Jonathan Brotchie Toronto, ON, Canada Maria Rosario Luquin Pamplona, Spain At the conclusion of this session, participants should be better able to: 1. Recognize the various animal models of Parkinson’s disease including rodents and non-human primates 2. Describe the features seen in the animal models of Parkinson’s disease 3. Discuss the use of animal models of Parkinson’s disease and their limitations Recommended Audience: Basic Scientists; Clinical Academicians; Students/Residents/Trainees 51 Daily Schedule Wednesday
Page 2 and 3: Claiming CME Credit To claim CME cr
Page 4 and 5: 2 Welcome Dear Colleagues and Frien
Page 6 and 7: About MDS 4 About MDS The Movement
Page 8 and 9: About MDS 6 About MDS Congress Loca
Page 10 and 11: MDS About Education MDS 8 Education
Page 12 and 13: MDS About Education MDS 10 Educatio
Page 14 and 15: MDS About Education MDS 12 Audio-Vi
Page 16 and 17: Membership About MDS 14 Connect wit
Page 18 and 19: Toronto Information About MDS 16 Do
Page 20 and 21: Toronto Information About MDS 18 To
Page 22 and 23: International Congress Information
Page 36 and 37: Daily Schedule 34 Session Definitio
Page 38 and 39: Daily Schedule Sunday Sunday and Mo
Page 40 and 41: Daily Schedule Monday 38 Monday, Ju
Page 42 and 43: Daily Schedule Monday 40 Monday, Ju
Page 44 and 45: Daily Schedule Monday and Tuesday t
Page 46 and 47: Daily Schedule Tuesday 44 Tuesday,
Page 48 and 49: Daily Schedule Tuesday 46 Tuesday,
Page 50 and 51: Daily Schedule Wednesday 48 Wednesd
Page 54 and 55: Daily Schedule Thursday 52 Wednesda
Page 56 and 57: Daily Schedule Thursday 54 Thursday
Page 58 and 59: Daily Schedule Thursday 56 Thursday
Page 60 and 61: Faculty Listing 58 Faculty Listing
Page 62 and 63: Faculty Listing 60 Faculty Listing
Page 64 and 65: Corporate Faculty Therapeutic Listi
Page 66 and 67: Leading Advances in DBS Patient Man
Page 68 and 69: This therapy is not for everyone. D
Page 70 and 71: Exhibits 68 Exhibitor Directory ABB
Page 72 and 73: Exhibits 70 Exhibitor Directory GE
Page 74 and 75: Exhibits 72 Exhibitor Directory MER
Page 76 and 77: Exhibits 74 Exhibitor Directory TEV
Page 78 and 79: Exhibits 76 Exhibitor Floor Plan
Page 80 and 81: Guided Poster Tours 78 Guided Poste
Page 88 and 89: Abstracts by topic 86 Abstracts by
Page 102 and 103:
Abstracts by topic 100 Abstracts by
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 131 and 132:
DBS | Advance A New Day in DBS The
show all

15th INTERNATIONAL CONGRESS OF PARKINSON'S

Create successful ePaper yourself

Delete template?

Save as template?